CD19 and precursor B-cell acute lymphoblastic leukemia: As a cell surface marker primarily found on B cells, CD19 serves as a key target in managing conditions such as B-cell acute lymphoblastic leukaemia (B-ALL) and non-Hodgkin lymphoma [46].